Diseases of hip joints
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Subjects aged 18-75 years; 2. The skeleton of the subjects is mature; 3. Subjects should have indications for total hip replacement; 4. The affected limb of the test side was the first time to receive total hip replacement; 5. Before the operation, the subjects were willing and able to sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. Neuromuscular dysfunction (e.g., paralysis, myolysis or abductor weakness) of subjects may lead to instability of hip joint or abnormal gait after operation; 2. The subjects are mentally incapable or unable to understand the requirements of participating in the study; 3. Alcoholics or drug addicts, objects of drug abuse; 4. Obese subjects with BMI > 35; 5. Patients with poor diabetes control (fasting blood glucose still >= 8.0mmol/l after drug control); 6. Patients with severe liver and kidney dysfunction; 7. Objects known to have a history of allergy to one or more implanted materials; 8. Patients with active infection in hip joint or other parts of the body; 9. Patients with serious osteoporosis, metabolic osteopathy, radiation osteopathy and tumor around hip joint; 10. Pregnant or lactating women or women planning pregnancy within 12 months; 11. Patients with general diseases (including coagulation dysfunction, serious heart disease, serious respiratory disease, other patients who can not tolerate anesthesia or surgery); those who are weak or cannot tolerate surgery due to other general diseases, with life expectancy less than 2 years; 12. The subject has participated in clinical research of other drugs, biological agents or medical devices before being selected, but failed to reach the time limit of main research end point; 13. Subjects with other diseases are limited to participate in the study and cannot follow up, which affects the scientific integrity of the study; 14. The subjects do not cooperate or are not conducive to treatment and postoperative rehabilitation exercise, and their compliance is expected to be poor; 15. The subjects had a history of hip surgery; 16. Other researchers think it is not suitable for this clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| radiographic data;Angle of Acetabular Cup; | — |
Secondary
| Measure | Time frame |
|---|---|
| Harris hip score;FJS-12 score; | — |
Countries
China
Contacts
Chinese PLA General Hospital